Ginseng Qi is helped up soft bag is obtained batch, security effectiveness obtains medical inspect branch to approbate.

Injection superintends Chinese traditional medicine strict, injection has the Chinese traditional medicine that approval of department of inspect of the medicine after 2008 appears on the market only 2. Ginseng Qi is helped up injecting complement of fluid soft in bags applies for to was referred 2006, in Chinese traditional medicine injection superintends strict, approval to measure few circumstance to fall, all previous classics 11 obtain careful of medical inspect branch to judge end of the year through, demonstrative ginseng Qi is helped up injecting the security of fluid and effectiveness get department of national medicine inspect approbate.

Soft bag is packed is prospective trend, promote product gain level and competitive advantage.

The soft bag photograph that pack is in to vitreous bottle quality, memory, carry and having distinct advantage with the respect such as medical safety. Bottle of Bo of predicting future our country will exit the market quickly, the market share that soft model packs will continue to increase, especially the market share of soft bag will increase quickly. Price of fluid of the soft bag inject that pack and wool interest rate all fluid of inject of bottle of prep above glass, at the same time ginseng Qi is helped up injecting fluid channel sinks growth can be in brought sales volume to did not cash continuously, predicting ginseng Qi is helped up injecting fluid sale and growth of gross profit hopeful.

Fight tumor Chinese traditional medicine injection breed is less, ginseng Qi is helped up hopeful replaces costly breed.

New edition cure maintains list to the Chinese traditional medicine of 26 breed injection is in by limitation 2 class and above medical establishment are used, among them great majority heats up agent of regulating blood condition for Qing Dynasty, do not include to fight tumor agent. In comparative and congener tumour officinal, ginseng Qi is helped up injecting fluid economy is good, charge of period of treatment and remedial day charge all are less than product of clinical and congener medicaments, prospective hopeful replaces costly breed further.

Gain is forecasted with investment grade.

Company research and development and sale pay equal attention to, heavy pound product followings sb's heels and come. Of short duration takes no account of land to transfer profit, we predict 17-19 year company EPS is 2.24/2.76/3.37 respectively yuan, current A the PE of share price correspondence is 29/24/20 times, maintain " buy " grade. According to current exchange rate, on June 28 H the PE of correspondence of closing quotation price is 21/17/14 times, give " buy " grade.